
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $187.1M | $208.1M | $246.8M | $274.4M | $293M | |
Revenue Growth (YoY) | -1.25% | 11.18% | 18.61% | 11.2% | 6.76% | |
Cost of Revenues | $54.3M | $59.8M | $70.8M | $79.3M | $76.3M | |
Gross Profit | $132.8M | $148.2M | $176M | $195.1M | $216.7M | |
Gross Profit Margin | 70.97% | 71.24% | 71.31% | 71.11% | 73.96% | |
R&D Expenses | $5.3M | $5.7M | $7.1M | $7.8M | $8.8M | |
Selling, General & Admin | $131M | $143.6M | $167.2M | $169.2M | $183.1M | |
Other Inc / (Exp) | $1.4M | -$531K | $13K | $2K | $9K | |
Operating Expenses | $136.4M | $150M | $188.7M | $177.1M | $194.5M | |
Operating Income | -$3.6M | -$1.8M | -$12.8M | $18M | $22.2M | |
Net Interest Expenses | -- | -- | $2.7M | $2.3M | -- | |
EBT. Incl. Unusual Items | -$2.3M | -$2.3M | -$15.5M | $15.8M | $23.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.6M | $9.5M | $2.4M | -$12.7M | $6.5M | |
Net Income to Company | -$620K | -$11.8M | -$17.9M | $28.5M | $17M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$620K | -$11.8M | -$17.9M | $28.5M | $17M | |
Basic EPS (Cont. Ops) | -$0.03 | -$0.60 | -$0.89 | $1.24 | $0.71 | |
Diluted EPS (Cont. Ops) | -$0.03 | -$0.60 | -$0.89 | $1.23 | $0.70 | |
Weighted Average Basic Share | $19.3M | $19.7M | $20.1M | $22.9M | $23.9M | |
Weighted Average Diluted Share | $19.3M | $19.7M | $20.1M | $23.2M | $24.1M | |
EBITDA | -$834K | $1.9M | $1.7M | $26.4M | $32.4M | |
EBIT | -$3.6M | -$1.8M | -$12.7M | $19.9M | $25.6M | |
Revenue (Reported) | $187.1M | $208.1M | $246.8M | $274.4M | $293M | |
Operating Income (Reported) | -$3.6M | -$1.8M | -$12.8M | $18M | $22.2M | |
Operating Income (Adjusted) | -$3.6M | -$1.8M | -$12.7M | $19.9M | $25.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $42.8M | $48M | $58.8M | $61.1M | $61.3M | |
Revenue Growth (YoY) | -2.07% | 12.17% | 22.65% | 3.81% | 0.3% | |
Cost of Revenues | $12.5M | $14.1M | $17.4M | $17.7M | $15.9M | |
Gross Profit | $30.2M | $33.9M | $41.5M | $43.4M | $45.3M | |
Gross Profit Margin | 70.68% | 70.58% | 70.47% | 71.09% | 74.01% | |
R&D Expenses | $1.3M | $1.5M | $2.2M | $2.1M | $1.7M | |
Selling, General & Admin | $33M | $40.1M | $41.7M | $43.6M | $47.5M | |
Other Inc / (Exp) | -$10K | -$456K | -$993K | $9K | -- | |
Operating Expenses | $34.3M | $48.8M | $45.3M | $46.4M | $49.9M | |
Operating Income | -$4.1M | -$14.9M | -$3.8M | -$3M | -$4.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$4.1M | -$15.4M | -$4.8M | -$2.8M | -$4.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.8M | $211K | -$2.9M | -$600K | -$1.1M | |
Net Income to Company | -$2.3M | -$15.6M | -$1.9M | -$2.2M | -$3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$2.3M | -$15.6M | -$1.9M | -$2.2M | -$3M | |
Basic EPS (Cont. Ops) | -$0.12 | -$0.78 | -$0.09 | -$0.09 | -$0.13 | |
Diluted EPS (Cont. Ops) | -$0.12 | -$0.78 | -$0.09 | -$0.09 | -$0.13 | |
Weighted Average Basic Share | $19.5M | $19.9M | $21.3M | $23.7M | $23.7M | |
Weighted Average Diluted Share | $19.5M | $19.9M | $21.3M | $23.7M | $23.7M | |
EBITDA | -$3.4M | -$7.8M | -$2.2M | -$608K | -$1.9M | |
EBIT | -$4.1M | -$14.9M | -$3.8M | -$2.2M | -$3.6M | |
Revenue (Reported) | $42.8M | $48M | $58.8M | $61.1M | $61.3M | |
Operating Income (Reported) | -$4.1M | -$14.9M | -$3.8M | -$3M | -$4.5M | |
Operating Income (Adjusted) | -$4.1M | -$14.9M | -$3.8M | -$2.2M | -$3.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $186.2M | $213.3M | $257.7M | $276.7M | $293.2M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $54.3M | $61.4M | $74.1M | $79.6M | $74.6M | |
Gross Profit | $132M | $151.8M | $183.6M | $197.1M | $218.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $4.9M | $5.9M | $7.8M | $7.7M | $8.4M | |
Selling, General & Admin | $130.2M | $150.7M | $168.8M | $171.1M | $187M | |
Other Inc / (Exp) | $1.1M | -$977K | -$524K | $3.5M | -$146K | |
Operating Expenses | $135.2M | $164.4M | $185.2M | $180.7M | $198M | |
Operating Income | -$3.3M | -$12.6M | -$1.7M | $16.4M | $20.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$2.2M | -$13.6M | -$4.9M | $17.8M | $22.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$591K | $11.6M | -$731K | -$10.4M | $6M | |
Net Income to Company | -$1.6M | -$25.1M | -$4.2M | $28.2M | $16.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$1.6M | -$25.1M | -$4.2M | $28.2M | $16.2M | |
Basic EPS (Cont. Ops) | -$0.10 | -$1.26 | -$0.20 | $1.21 | $0.66 | |
Diluted EPS (Cont. Ops) | -$0.11 | -$1.26 | -$0.20 | $1.20 | $0.66 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$545K | -$2.4M | $7.4M | $25.5M | $31.8M | |
EBIT | -$3.3M | -$12.6M | -$1.6M | $19M | $24.9M | |
Revenue (Reported) | $186.2M | $213.3M | $257.7M | $276.7M | $293.2M | |
Operating Income (Reported) | -$3.3M | -$12.6M | -$1.7M | $16.4M | $20.6M | |
Operating Income (Adjusted) | -$3.3M | -$12.6M | -$1.6M | $19M | $24.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $42.8M | $48M | $58.8M | $61.1M | $61.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $12.5M | $14.1M | $17.4M | $17.7M | $15.9M | |
Gross Profit | $30.2M | $33.9M | $41.5M | $43.4M | $45.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $1.3M | $1.5M | $2.2M | $2.1M | $1.7M | |
Selling, General & Admin | $33M | $40.1M | $41.7M | $43.6M | $47.5M | |
Other Inc / (Exp) | -$10K | -$456K | -$993K | $9K | -- | |
Operating Expenses | $34.3M | $48.8M | $45.3M | $46.4M | $49.9M | |
Operating Income | -$4.1M | -$14.9M | -$3.8M | -$3M | -$4.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$4.1M | -$15.4M | -$4.8M | -$2.8M | -$4.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.8M | $211K | -$2.9M | -$600K | -$1.1M | |
Net Income to Company | -$2.3M | -$15.6M | -$1.9M | -$2.2M | -$3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$2.3M | -$15.6M | -$1.9M | -$2.2M | -$3M | |
Basic EPS (Cont. Ops) | -$0.12 | -$0.78 | -$0.09 | -$0.09 | -$0.13 | |
Diluted EPS (Cont. Ops) | -$0.12 | -$0.78 | -$0.09 | -$0.09 | -$0.13 | |
Weighted Average Basic Share | $19.5M | $19.9M | $21.3M | $23.7M | $23.7M | |
Weighted Average Diluted Share | $19.5M | $19.9M | $21.3M | $23.7M | $23.7M | |
EBITDA | -$3.4M | -$7.8M | -$2.2M | -$608K | -$1.9M | |
EBIT | -$4.1M | -$14.9M | -$3.8M | -$2.2M | -$3.6M | |
Revenue (Reported) | $42.8M | $48M | $58.8M | $61.1M | $61.3M | |
Operating Income (Reported) | -$4.1M | -$14.9M | -$3.8M | -$3M | -$4.5M | |
Operating Income (Adjusted) | -$4.1M | -$14.9M | -$3.8M | -$2.2M | -$3.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $47.9M | $28.2M | $21.9M | $61M | $94.4M | |
Short Term Investments | $10.7M | $12.5M | $16.1M | $14.2M | $14.5M | |
Accounts Receivable, Net | $43.8M | $49.5M | $54.8M | $43.2M | $44.9M | |
Inventory | $18.6M | $19.2M | $23.1M | $22.5M | $18.7M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $2.6M | $4.1M | $3.8M | $4.4M | $5.1M | |
Total Current Assets | $123.6M | $113.5M | $119.8M | $145.3M | $177.6M | |
Property Plant And Equipment | $27.1M | $30.7M | $27.4M | $25.3M | $22.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $31.1M | $31.1M | $31.1M | $31.1M | |
Other Intangibles | $1.7M | $54.1M | $50.4M | $46.7M | $42.8M | |
Other Long-Term Assets | $2.1M | $2M | $3.3M | $2.7M | $6M | |
Total Assets | $174.1M | $244.3M | $255M | $281.4M | $297.9M | |
Accounts Payable | $4.2M | $5M | $10M | $6.7M | $5.6M | |
Accrued Expenses | $14.2M | $17.3M | $26.2M | $22.5M | $24.9M | |
Current Portion Of Long-Term Debt | -- | $3M | $3M | $3M | $3M | |
Current Portion Of Capital Lease Obligations | $2M | $2.5M | $2.5M | $2.8M | $3M | |
Other Current Liabilities | $1.8M | $6.6M | $20.2M | $4.5M | $3.1M | |
Total Current Liabilities | $26.7M | $34.5M | $64.3M | $41.1M | $40.7M | |
Long-Term Debt | -- | $51.8M | $45.9M | $26.2M | $23.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $49.3M | $116M | $133.6M | $87.8M | $81.3M | |
Common Stock | $19K | $20K | $20K | $24K | $24K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $124.8M | $128.2M | $121.4M | $193.6M | $216.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $124.8M | $128.2M | $121.4M | $193.6M | $216.6M | |
Total Liabilities and Equity | $174.1M | $244.3M | $255M | $281.4M | $297.9M | |
Cash and Short Terms | $58.6M | $40.7M | $38.1M | $75.2M | $108.9M | |
Total Debt | -- | $54.8M | $48.9M | $29.1M | $26.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $46.9M | $21.2M | $55M | $60.7M | $83.6M | |
Short Term Investments | $11.3M | $12.3M | $13.8M | $14.3M | $14.9M | |
Accounts Receivable, Net | $40M | $45.9M | $51M | $40.5M | $35.7M | |
Inventory | $22M | $19.5M | $20M | $20.8M | $18.9M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $2.2M | $4.4M | $4.9M | $4.9M | $5.9M | |
Total Current Assets | $122.5M | $103.2M | $145.4M | $141.3M | $160.1M | |
Property Plant And Equipment | $26.3M | $29.6M | $26.3M | $24.7M | $21.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $31.1M | $31.1M | $31.1M | $31.1M | |
Other Intangibles | $1.7M | $53.2M | $49.5M | $45.8M | $41.9M | |
Other Long-Term Assets | $2M | $2.3M | $3.3M | $3M | $7.6M | |
Total Assets | $175.3M | $233M | $275.5M | $272M | $280.2M | |
Accounts Payable | $9.4M | $6.2M | $9.6M | $5.5M | $7.2M | |
Accrued Expenses | $10M | $13.1M | $18M | $17.7M | $17.2M | |
Current Portion Of Long-Term Debt | -- | $3M | $3M | $3M | $3M | |
Current Portion Of Capital Lease Obligations | $2M | $2.5M | $2.5M | $2.7M | $3M | |
Other Current Liabilities | $2.2M | $13.4M | $18.3M | $3.3M | $4.1M | |
Total Current Liabilities | $28M | $40.3M | $51.4M | $33.1M | $35.4M | |
Long-Term Debt | -- | $48.1M | $45.2M | $25.4M | $22.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $50.2M | $118M | $119.3M | $78.6M | $74.6M | |
Common Stock | $20K | $20K | $23K | $24K | $24K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $125.1M | $115M | $156.2M | $193.5M | $205.6M | |
Total Liabilities and Equity | $175.3M | $233M | $275.5M | $272M | $280.2M | |
Cash and Short Terms | $58.2M | $33.5M | $68.8M | $75M | $98.5M | |
Total Debt | -- | $51M | $48.1M | $28.4M | $25.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$620K | -$11.8M | -$17.9M | $28.5M | $17M | |
Depreciation & Amoritzation | $2.8M | $3.7M | $6.3M | $6.5M | $6.8M | |
Stock-Based Compensation | $10.7M | $10.2M | $9.6M | $7.5M | $7.8M | |
Change in Accounts Receivable | -$15.7M | -$9M | -$15.6M | $23.8M | $9.2M | |
Change in Inventories | $318K | $972K | -$3.9M | $597K | $3.9M | |
Cash From Operations | $2.8M | $2.6M | $5.2M | $35.9M | $40.7M | |
Capital Expenditures | $2.3M | $2.4M | $1.9M | $2.5M | $2.5M | |
Cash Acquisitions | -- | -$79.8M | -- | -- | -- | |
Cash From Investing | $20.2M | -$82.2M | -$1.9M | -$2.5M | -$2.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $55M | -- | $8.3M | -- | |
Long-Term Debt Repaid | -- | -- | -$6M | -$28M | -$3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$3.5M | |
Other Financing Activities | -$1.9M | -$1.4M | -$5M | -$10.7M | -- | |
Cash From Financing | $2.1M | $59.9M | -$9.6M | $5.7M | -$4.8M | |
Beginning Cash (CF) | $22.8M | $47.9M | $28.2M | $21.9M | $61M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $25.1M | -$19.6M | -$6.3M | $39.1M | $33.3M | |
Ending Cash (CF) | $47.9M | $28.2M | $21.9M | $61M | $94.4M | |
Levered Free Cash Flow | $503K | $276K | $3.3M | $33.4M | $38.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.3M | -$15.6M | -$1.9M | -$2.2M | -$3M | |
Depreciation & Amoritzation | $652K | $1.5M | $1.6M | $1.6M | $1.7M | |
Stock-Based Compensation | $2.5M | $2.2M | $2M | $2M | $2.1M | |
Change in Accounts Receivable | $2.5M | $2.8M | $6.9M | $6.7M | $9.2M | |
Change in Inventories | -$3.5M | -$262K | $3.1M | $1.7M | -$201K | |
Cash From Operations | -$800K | -$3.2M | -$502K | $924K | $417K | |
Capital Expenditures | $311K | $175K | $291K | $502K | $407K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$311K | -$175K | -$291K | -$502K | -$407K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$3.8M | -$750K | -$750K | -$750K | |
Repurchase of Common Stock | -- | -- | -- | -- | -$10M | |
Other Financing Activities | -$1.1M | -$39K | -- | -- | -- | |
Cash From Financing | $181K | -$3.7M | $33.9M | -$749K | -$10.8M | |
Beginning Cash (CF) | $47.9M | $28.2M | $21.9M | $61M | $94.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$930K | -$7.1M | $33.1M | -$327K | -$10.7M | |
Ending Cash (CF) | $46.9M | $21.2M | $55M | $60.7M | $83.6M | |
Levered Free Cash Flow | -$1.1M | -$3.4M | -$793K | $422K | $10K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.6M | -$25.1M | -$4.2M | $28.2M | $16.2M | |
Depreciation & Amoritzation | $2.7M | $4.6M | $6.4M | $6.5M | $6.9M | |
Stock-Based Compensation | $10.4M | $9.9M | $9.4M | $7.6M | $7.8M | |
Change in Accounts Receivable | -$14.8M | -$8.7M | -$11.5M | $23.6M | $11.8M | |
Change in Inventories | $143K | $4.2M | -$535K | -$830K | $2M | |
Cash From Operations | $1.1M | $225K | $7.9M | $37.3M | $40.1M | |
Capital Expenditures | $2.2M | $2.2M | $2M | $2.7M | $2.4M | |
Cash Acquisitions | -- | -$79.8M | -- | -- | -- | |
Cash From Investing | $10.3M | -$82M | -$2M | -$2.7M | -$2.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$3.8M | -$3M | -$28M | -$3M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.8M | -$285K | -- | -- | -- | |
Cash From Financing | $3.3M | $56M | $28M | -$28.9M | -$14.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $14.6M | -$25.8M | $33.9M | $5.7M | $22.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$1.1M | -$2M | $5.9M | $34.6M | $37.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.3M | -$15.6M | -$1.9M | -$2.2M | -$3M | |
Depreciation & Amoritzation | $652K | $1.5M | $1.6M | $1.6M | $1.7M | |
Stock-Based Compensation | $2.5M | $2.2M | $2M | $2M | $2.1M | |
Change in Accounts Receivable | $2.5M | $2.8M | $6.9M | $6.7M | $9.2M | |
Change in Inventories | -$3.5M | -$262K | $3.1M | $1.7M | -$201K | |
Cash From Operations | -$800K | -$3.2M | -$502K | $924K | $417K | |
Capital Expenditures | $311K | $175K | $291K | $502K | $407K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$311K | -$175K | -$291K | -$502K | -$407K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$3.8M | -$750K | -$750K | -$750K | |
Repurchase of Common Stock | -- | -- | -- | -- | -$10M | |
Other Financing Activities | -$1.1M | -$39K | -- | -- | -- | |
Cash From Financing | $181K | -$3.7M | $33.9M | -$749K | -$10.8M | |
Beginning Cash (CF) | $47.9M | $28.2M | $21.9M | $61M | $94.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$930K | -$7.1M | $33.1M | -$327K | -$10.7M | |
Ending Cash (CF) | $46.9M | $21.2M | $55M | $60.7M | $83.6M | |
Levered Free Cash Flow | -$1.1M | -$3.4M | -$793K | $422K | $10K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.